サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1471456

患者モニタリング装置の世界市場：製品別、ユーザー別、顧客のアンメットニーズ - 2029年までの予測

Patient Monitoring Devices Market by Product (Cardiac monitoring devices, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, blood pressure monitors, ECG, ICP, weight Monitoring), User, Customer Unmet Needs- Global Forecast to 2029
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 409 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
患者モニタリング装置の世界市場：製品別、ユーザー別、顧客のアンメットニーズ - 2029年までの予測
出版日: 2024年04月17日
発行: MarketsandMarkets
ページ情報: 英文 409 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の患者モニタリング装置の市場規模は、2024年の485億米ドルから2029年には711億米ドルに達し、予測期間中のCAGRは8.0％になると予測されています。

患者モニタリングは、人口の高齢化、ワイヤレスモニタリング装置、バイオセンサーの使用の増加、より高度なモニタリング装置を備えた病院やクリニックの増加によって推進されます。さらに、償還プログラムを通じて遠隔医療と遠隔患者モニタリング（RPM）を促進する政府のイニシアチブは、市場拡大の促進要因として機能します。これらの要因は、今後予測される数年間において、ヘルスケアの提供と患者の転帰を改善する上で中心的な役割を果たします。

調査範囲
調査対象年 2022年～2029年
基準年 2023年
予測期間 2024年～2029年
検討単位 金額（10億米ドル）
セグメント 製品別、エンドユーザー別、地域別
対象地域 北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ

製品別では、血糖モニタリングシステム分野が2024年～2029年の予測期間で最大の市場シェアを記録しました。このセグメントの成長は、糖尿病の有病率の上昇によるもので、最適な糖尿病管理を達成し、長期的な合併症を軽減するためには、早期発見、継続的なモニタリング、厳格な血糖コントロールが重要です。特定のBGMSにAI機能を統合することで、患者にパーソナライズされたデータ主導の洞察を生み出し、より多くの情報に基づいた自己管理の意思決定を行えるようになる可能性があります。さらに、糖尿病管理のための支援政策やBGMSの償還プログラムの進化は、これらの技術への患者のアクセスを増加させることができます。

エンドユーザー別では、2023年には、病院・診療所セグメントが世界の患者モニタリング市場で最大のシェアを占めました。病院・診療所セグメントの成長は、慢性疾患の有病率の上昇、潜在的合併症の早期発見のための高度な患者モニター、継続的な高度モニタリング技術、より良いデータ管理と分析のための電子カルテ（EHR）との統合などの要因によって推進されています。

アジア太平洋市場は、遠隔医療サービスと遠隔モニタリング機能の拡大により成長を経験しています。その他の特典として、在宅介護環境の増加、高齢者人口の増加、加齢に関連する症状の影響を受けやすく、より緊密なモニタリングと管理が必要であることから、アジア太平洋地域でモニタリング製品の提供を拡大しています。

当レポートでは、世界の患者モニタリング装置市場について調査し、製品別、ユーザー別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
  • ポーターのファイブフォース分析
  • 規制分析
  • 主要な規制ガイドライン
  • 払い戻しシナリオ
  • エコシステム分析
  • 患者モニタリング市場における主要な市場参入企業
  • 投資と資金調達のシナリオ
  • 技術分析
  • バリューチェーン分析
  • サプライチェーン分析
  • 価格分析
  • 特許分析
  • 貿易分析
  • 2024年～2025年の主な会議とイベント
  • 顧客のビジネスに影響を与える動向/混乱
  • 主な利害関係者と購入基準
  • 患者モニタリング市場：景気後退の影響
  • アンメットニーズと主な問題点

第6章 患者モニタリング装置市場（製品別）

  • イントロダクション
  • 血糖値モニタリング装置
  • 心臓モニタリング装置
  • マルチパラメータモニタリング装置
  • 呼吸モニタリング装置
  • 温度監視装置
  • 血行動態/圧力モニタリング装置
  • 胎児および新生児モニタリング装置
  • 神経モニタリング装置
  • 体重モニタリング装置
  • その他の患者モニタリング装置

第7章 患者モニタリング装置市場（エンドユーザー別）

  • イントロダクション
  • 病院・診療所
  • 外来手術センター
  • 在宅ケア
  • その他

第8章 患者モニタリング装置市場（地域別）

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合情勢

  • 概要
  • 主要参入企業の戦略/秘策
  • 収益分析
  • 市場シェア分析
  • 企業評価マトリックス：主要参入企業
  • 企業評価マトリックス：スタートアップ/中小企業
  • 競合シナリオ
  • 企業評価と財務指標
  • 製品/ブランド比較

第10章 企業プロファイル

  • 主要参入企業
    • MEDTRONIC PLC
    • ABBOTT LABORATORIES
    • DEXCOM, INC.
    • GE HEALTHCARE
    • PHILIPS HEALTHCARE
    • NIHON KOHDEN CORPORATION
    • MINDRAY MEDICAL INTERNATIONAL LTD.
    • EDWARDS LIFESCIENCES CORPORATION
    • GETINGE AB
    • BAXTER INTERNATIONAL（HILL-ROM HOLDINGS, INC.）
    • DRAGERWERK AG & CO. KGAA
    • BOSTON SCIENTIFIC CORPORATION
    • MASIMO CORPORATION
    • OMRON CORPORATION
    • ARCHIMED SAS（NATUS MEDICAL）
    • COMPUMEDICS LIMITED
    • NONIN MEDICAL, INC.
  • その他の企業
    • BIOTRONIK
    • SCHILLER AG
    • SENSEONICS
    • CARDIOMO
    • VITLS
    • NETEERA
    • QARDIO
    • VIVIFY HEALTH
    • IRHYTHM TECHNOLOGIES, INC.
    • OSYPKA MEDICAL
    • CARDINAL HEALTH
    • MERIT MEDICAL SYSTEMS

第11章 付録

目次
Product Code: MD 2436

The global patient monitoring devices market is projected to reach USD 71.1 billion by 2029 from USD 48.5 billion in 2024, growing at a CAGR of 8.0% during the forecast period. The projected market growth for patient monitoring is supported by the convergence of benefits. Patient monitoring are driven by an aging population, increasing use of wireless monitoring devices, biosensors, and an increasing number of hospitals & clinics with more advanced monitoring devices. Furthermore, Government initiatives promoting telehealth and remote patient monitoring (RPM) through reimbursement programs can act as a catalyst for market expansion. These factors play a central role in improving healthcare delivery and patient outcomes in the coming forecasting years.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD) Billion
SegmentsProduct, End User and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa

"Blood glucose monitoring systems segment to register largest market share in 2023-2029."

Based on the product, the patient monitoring devices market is segmented into Blood glucose monitoring systems, Cardiac monitoring Devices (ECG Devices, Implantable loop recorders, Event monitors, MCT Monitors, Smart/Wearable ECG Monitors), Multi-Parameter Monitoring, Respiratory Monitoring Devices, Hemodynamic/ Pressure Monitoring Devices, Weight Monitoring Devices, Fetal & Neonatal Monitoring Devices, Neuromonitoring Devices, Temperature Monitoring Devices and others are used in patient monitoring considered for the overall market estimation. The blood glucose monitoring systems segment registered the largest market share over the forecast period of 2024-2029. The growth of this segment is due to the Rising Prevalence of Diabetes, for achieving optimal diabetes management and mitigating long-term complications hinge on early detection, continuous monitoring, and strict glycemic control. The integration of AI functionalities in certain BGMS offers the potential to generate personalized, data-driven insights for patients, empowering them to make more informed self-management decisions. Moreover, evolving Supportive policies for diabetes management and reimbursement programs for BGMS can increase patient access to these technologies.

"Hospitals & Clinics segment held the largest share of patient monitoring market in 2023, by End-user."

Based on the end-user, the patient monitoring devices market is segmented into Hospitals & clinics, Ambulatory surgical centers and home care settings. In 2023, the hospitals & clinics segment accounted for the largest share of the global patient monitoring market. The growth of hospital & clinic segment is being propelled by factors including Rising Prevalence of Chronic Diseases, advanced patient monitors for earlier identification of potential complications, continuous advanced monitoring technologies, and integration with electronic health records (EHR) for better data management and analysis.

"Asia Pacific to register significant growth rate in the market during the forecast period."

For the forecasting period 2024-2029, the APAC region is expected to register a significant growth rate during the forecast period. Asia Pacific comprises India, China, Japan, South Korea, Australia, and RoAPAC. The Asia-Pacific (APAC) region has witnessed a significant increase in the market growth rate for patient monitoring. There are several drivers that contributed to the growth:

The Asia Pacific market is experiencing growth due to expansion of telehealth services & remote monitoring capabilities. Additionally, the market is benefiting from the rise in home care settings, rising geriatric population is more susceptible to age-related conditions, requiring closer monitoring and management to expand their offerings of monitoring products in the Asia Pacific region.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-40%, Tier 2-30%, and Tier 3- 30%
  • By Designation: C-level-- 27%, Director-level-18%, and Others-55%
  • By Region: North America-50%, Europe-20%, Asia Pacific-15%, Latin America-10%, and the Middle East & Africa-5%

Prominent players in this market are Medtronic (Ireland), GE Healthcare (US), Abbott Laboratories (US), Nihon Kohden Corporation (Japan), Philips healthcare (Netherland) among others.

Research Coverage

  • The report studies the patient monitoring market based on products, end user, and region.
  • The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
  • The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
  • The report studies micro markets with respect to their growth trends, prospects, and contributions to the global patient monitoring market.
  • The report forecasts the revenue of market segments with respect to five major regions.

Key Benefits of Buying the Report:

The report will help the new entrants/ market leaders/smaller firms in this market with investment evaluation viability within the patient monitoring market through a thorough analysis of comprehensive data, thereby facilitating robust risk assessment and enabling well-informed investment determinations. Benefit from meticulous market segmentation encompassing end-user, and regional dimensions, affording tailored insights for precise segment targeting. The report also provides an all-encompassing evaluation of encapsulating pivotal trends, challenges, growth catalysts and prospects, thereby empowering strategic decision-making with astute discernment.

The report provides insights on the following pointers:

  • Analysis of key drivers (rising prevalence of chronic disorder diseases, aging population, Increased Focus on Early Detection and Intervention), restraints (high cost of monitoring systems, Resource-constrained settings in developing countries), opportunities (advancements in manufacturing and miniaturization of components can potentially lead to more affordable patient monitoring solutions, growth of medical tourism), and challenges (unskilled professionals) influencing the growth of the patient monitoring market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the patient monitoring market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the patient monitoring market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the patient monitoring market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Medtronic (Ireland), GE Healthcare (US), Abbott Laboratories (US), Nihon Kohden Corporation (Japan), among others.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 REGIONS COVERED
  • 1.4 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
  • 1.6 RESEARCH LIMITATIONS
  • 1.7 MARKET STAKEHOLDERS
  • 1.8 SUMMARY OF CHANGES
  • 1.9 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH DESIGN
    • 2.2.1 SECONDARY RESEARCH
    • FIGURE 1 KEY DATA FROM SECONDARY SOURCES
    • 2.2.2 PRIMARY RESEARCH
      • 2.2.2.1 Primary sources
      • 2.2.2.2 Key industry insights
      • 2.2.2.3 Breakdown of primaries
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION
    • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Approach 1: Company revenue estimation approach
    • FIGURE 5 PATIENT MONITORING MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
      • 2.3.1.2 Approach 2: Customer-based market estimation
    • FIGURE 6 PATIENT MONITORING MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.3.2 TOP-DOWN APPROACH
    • FIGURE 7 PATIENT MONITORING MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
    • 2.3.3 PRIMARY INTERVIEWS
  • 2.4 DATA TRIANGULATION & MARKET BREAKDOWN
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.5 MARKET SHARE ASSESSMENT
  • 2.6 STUDY ASSUMPTIONS
  • 2.7 MARKET FORECASTING METHODOLOGY
    • FIGURE 9 GROWTH PROJECTIONS WERE BASED ON REVENUE IMPACT OF KEY MACROINDICATORS
  • 2.8 RISK ASSESSMENT
    • TABLE 1 LIMITATIONS AND ASSOCIATED RISKS
  • 2.9 GROWTH RATE ASSUMPTIONS
  • 2.10 RECESSION IMPACT ON PATIENT MONITORING MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 10 PATIENT MONITORING MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
    • FIGURE 11 PATIENT MONITORING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
    • FIGURE 12 GEOGRAPHICAL SNAPSHOT OF PATIENT MONITORING MARKET

4 PREMIUM INSIGHTS

  • 4.1 PATIENT MONITORING MARKET OVERVIEW
    • FIGURE 13 GROWING ADOPTION OF WIRELESS MONITORING DEVICES TO DRIVE MARKET GROWTH
  • 4.2 PATIENT MONITORING MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
    • FIGURE 14 ASIA PACIFIC MARKET TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • 4.3 PATIENT MONITORING MARKET, BY REGION AND END USER, 2023 (USD MILLION)
    • FIGURE 15 HOSPITALS & CLINICS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • 4.4 GEOGRAPHIC SNAPSHOT OF PATIENT MONITORING MARKET
    • FIGURE 16 JAPAN TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 17 PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Emergence of predictive analytics in vital sign monitors
      • 5.2.1.2 Growing preference for wearable patient monitoring devices, biosensors, and smart implants
      • 5.2.1.3 Availability of wireless monitoring devices
      • 5.2.1.4 Expansion of telehealth services and remote monitoring capabilities
      • 5.2.1.5 Growing incidence of chronic diseases
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Risks associated with invasive monitoring devices
      • 5.2.2.2 High cost of patient monitoring products and inadequate reimbursement
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Integration with electronic health records (EHRs)
      • 5.2.3.2 Expansion of remote patient monitoring in home healthcare settings
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of personnel and limited awareness & education for patient monitoring devices
      • 5.2.4.2 Increased pricing pressure on market players
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 2 PATIENT MONITORING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT OF NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF SUPPLIERS
    • 5.3.4 BARGAINING POWER OF BUYERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 REGULATORY ANALYSIS
    • TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 5 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.5 KEY REGULATORY GUIDELINES
    • 5.5.1 NORTH AMERICA
      • 5.5.1.1 US
    • TABLE 8 US: CLASSIFICATION OF MEDICAL EQUIPMENT
    • TABLE 9 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
      • 5.5.1.2 Canada
    • TABLE 10 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.5.2 EUROPE
    • TABLE 11 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.5.3 ASIA PACIFIC
      • 5.5.3.1 Japan
    • TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
      • 5.5.3.2 India
      • 5.5.3.3 China
  • 5.6 REIMBURSEMENT SCENARIO
    • TABLE 13 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 KEY MARKET PLAYERS IN PATIENT MONITORING MARKET
  • 5.9 INVESTMENT & FUNDING SCENARIO
    • FIGURE 18 NUMBER OF INVESTOR DEALS IN PATIENT MONITORING MARKET, BY KEY PLAYER, 2018-2022
    • FIGURE 19 VALUE OF INVESTOR DEALS IN PATIENT MONITORING MARKET, BY KEY PLAYER, 2018-2022 (USD MILLION)
  • 5.10 TECHNOLOGY ANALYSIS
    • 5.10.1 KEY TECHNOLOGIES
      • 5.10.1.1 Smart wearable monitoring devices
      • 5.10.1.2 Vital sign monitors
    • 5.10.2 COMPLEMENTARY TECHNOLOGIES
      • 5.10.2.1 Remote patient monitors
      • 5.10.2.2 AI & IoT
      • 5.10.2.3 Telehealth
    • 5.10.3 ADJACENT TECHNOLOGIES
      • 5.10.3.1 IVD
      • 5.10.3.2 Medical imaging
  • 5.11 VALUE CHAIN ANALYSIS
    • 5.11.1 RESEARCH & DEVELOPMENT
    • 5.11.2 PROCUREMENT AND PRODUCT DEVELOPMENT
    • 5.11.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
    • FIGURE 20 PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS
  • 5.12 SUPPLY CHAIN ANALYSIS
    • 5.12.1 PROMINENT COMPANIES
    • 5.12.2 SMALL & MEDIUM-SIZED COMPANIES
    • 5.12.3 END USERS
    • FIGURE 21 PATIENT MONITORING MARKET: SUPPLY CHAIN ANALYSIS
  • 5.13 PRICING ANALYSIS
    • FIGURE 22 AVERAGE SELLING PRICE OF PATIENT MONITORING DEVICES, BY PRODUCT (FY 2021-2023)
    • FIGURE 23 AVERAGE SELLING PRICE TREND OF PATIENT MONITORING DEVICES, BY REGION, 2021-2023 (USD)
  • 5.14 PATENT ANALYSIS
    • FIGURE 24 PATENT DETAILS FOR PATIENT MONITORING DEVICES (JANUARY 2013-DECEMBER 2023)
  • 5.15 TRADE ANALYSIS
    • TABLE 14 IMPORT DATA FOR PATIENT MONITORING DEVICES (HS CODE 9018), BY COUNTRY, 2018-2022 (USD THOUSAND)
    • TABLE 15 EXPORT DATA FOR PATIENT MONITORING DEVICES (HS CODE 9018), BY COUNTRY, 2018-2022 (USD THOUSAND)
  • 5.16 KEY CONFERENCES & EVENTS, 2024-2025
    • TABLE 16 PATIENT MONITORING MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS IN 2024-2025
  • 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 25 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
  • 5.18 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.18.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • TABLE 17 KEY REQUIREMENTS OF DEPARTMENTS/STAKEHOLDERS WHILE BUYING PATIENT MONITORING DEVICES
    • 5.18.2 BUYING CRITERIA
    • FIGURE 26 BUYING CRITERIA
    • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PATIENT MONITORING DEVICES
    • TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%)
  • 5.19 PATIENT MONITORING MARKET: RECESSION IMPACT
  • 5.20 UNMET NEEDS & KEY PAIN POINTS
    • TABLE 19 PATIENT MONITORING MARKET: UNMET CUSTOMER NEEDS & KEY PAIN POINTS

6 PATIENT MONITORING MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 20 PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • 6.2 BLOOD GLUCOSE MONITORING DEVICES
    • TABLE 21 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 22 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 23 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 6.2.1 SELF-MONITORING BLOOD GLUCOSE DEVICES
      • 6.2.1.1 Rising adoption of integrated glucose monitoring devices to drive growth
    • TABLE 24 SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.2 CONTINUOUS GLUCOSE MONITORING DEVICES
      • 6.2.2.1 Product launches and evolving reimbursement scenarios for continuous monitoring devices to drive market growth
    • TABLE 25 CONTINUOUS GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.3 WEARABLE GLUCOSE MONITORING DEVICES
      • 6.2.3.1 Growing patient inclination towards wearable monitors to boost market
    • TABLE 26 WEARABLE GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.3 CARDIAC MONITORING DEVICES
    • TABLE 27 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 28 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 29 CARDIAC MONITORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 6.3.1 ECG DEVICES
      • 6.3.1.1 Low cost and wide applications of ECG devices to drive market growth
    • TABLE 30 ECG DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.3.2 IMPLANTABLE LOOP RECORDERS (ILRS)
      • 6.3.2.1 High cost and limited applications to limit growth
    • TABLE 31 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.3.3 EVENT MONITORS
      • 6.3.3.1 Emergence of portable and wireless event monitors to drive market growth
    • TABLE 32 EVENT MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.3.4 MCT MONITORS
      • 6.3.4.1 Availability of alternate technologies to hinder market growth
    • TABLE 33 MCT MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.3.5 SMART/WEARABLE ECG MONITORS
      • 6.3.5.1 Need to minimize treatment costs for CVD patients to increase adoption of smart/wearable ECG monitors
    • TABLE 34 SMART/WEARABLE ECG MONITORS OFFERED BY MARKET PLAYERS
    • TABLE 35 SMART/WEARABLE ECG MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.4 MULTIPARAMETER MONITORING DEVICES
    • TABLE 36 MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 37 MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 38 MULTIPARAMETER MONITORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 6.4.1 LOW-ACUITY MONITORS
      • 6.4.1.1 Increasing adoption of low-acuity monitors in general wards to drive market growth
    • TABLE 39 LOW-ACUITY MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.4.2 MID-ACUITY MONITORS
      • 6.4.2.1 Rising geriatric population to increase market growth
    • TABLE 40 MID-ACUITY MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.4.3 HIGH-ACUITY MONITORS
      • 6.4.3.1 Increasing partnerships between manufacturers and hospitals & clinics to drive device sales
    • TABLE 41 HIGH-ACUITY MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.5 RESPIRATORY MONITORING DEVICES
    • TABLE 42 RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 43 RESPIRATORY MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 44 RESPIRATORY MONITORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 6.5.1 PULSE OXIMETERS
      • 6.5.1.1 Rising adoption of pulse oximeters in home care settings to drive market growth
    • TABLE 45 PULSE OXIMETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.5.2 SPIROMETERS
      • 6.5.2.1 Technological advancements to increase adoption of spirometers
    • TABLE 46 SPIROMETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.5.3 CAPNOGRAPHS
      • 6.5.3.1 Product development and growing commercial acceptance to drive market growth
    • TABLE 47 CAPNOGRAPHS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.5.4 PEAK FLOW METERS
      • 6.5.4.1 Low preference for peak flow meters due to high variability in measurements from different devices to hinder market growth
    • TABLE 48 PEAK FLOW METERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.6 TEMPERATURE MONITORING DEVICES
    • TABLE 49 TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 50 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 51 TEMPERATURE MONITORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 6.6.1 HANDHELD TEMPERATURE MONITORING DEVICES
      • 6.6.1.1 Advantages associated with handheld temperature monitoring devices to drive market growth
    • TABLE 52 HANDHELD TEMPERATURE MONITORING DEVICES OFFERED BY MARKET PLAYERS
    • TABLE 53 HANDHELD TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.6.2 TABLE-TOP TEMPERATURE MONITORING DEVICES
      • 6.6.2.1 Increasing risks associated with hypothermia during surgeries to drive demand for table-top devices
    • TABLE 54 TABLE-TOP TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.6.3 WEARABLE CONTINUOUS MONITORING DEVICES
      • 6.6.3.1 Versatile functionalities offered by wearable continuous monitoring devices to drive demand
    • TABLE 55 WEARABLE CONTINUOUS MONITORING DEVICES OFFERED BY MARKET PLAYERS
    • TABLE 56 WEARABLE CONTINUOUS MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.6.4 INVASIVE TEMPERATURE MONITORING DEVICES
      • 6.6.4.1 Risk of bloodstream infections associated with catheter usage to hinder market for invasive devices
    • TABLE 57 INVASIVE TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.6.5 SMART TEMPERATURE MONITORING PATCHES
      • 6.6.5.1 Long-term monitoring capabilities of smart patches to drive market growth
    • TABLE 58 SMART TEMPERATURE MONITORING PATCHES OFFERED BY MARKET PLAYERS
    • TABLE 59 SMART TEMPERATURE MONITORING PATCHES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.7 HEMODYNAMIC/PRESSURE MONITORING DEVICES
    • TABLE 60 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 61 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 62 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 6.7.1 HEMODYNAMIC MONITORS
      • 6.7.1.1 Influx of VC funding to drive market growth
    • TABLE 63 HEMODYNAMIC MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.7.2 BLOOD PRESSURE MONITORS
      • 6.7.2.1 Development of wearable blood pressure monitors to drive market growth
    • TABLE 64 WEARABLE BLOOD PRESSURE MONITORS OFFERED BY MARKET PLAYERS
    • TABLE 65 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.7.3 DISPOSABLES
      • 6.7.3.1 Growing number of surgical procedures to drive growth in disposables market
    • TABLE 66 HEMODYNAMIC/PRESSURE MONITORING DISPOSABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.8 FETAL & NEONATAL MONITORING DEVICES
    • TABLE 67 FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 68 FETAL & NEONATAL MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 69 FETAL & NEONATAL MONITORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 6.8.1 FETAL MONITORING DEVICES
      • 6.8.1.1 Rising prevalence of obstetric complications to drive market growth
    • TABLE 70 WEARABLE FETAL MONITORING & OBSTETRIC DEVICES OFFERED BY MARKET PLAYERS
    • TABLE 71 FETAL MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.8.2 NEONATAL MONITORING DEVICES
      • 6.8.2.1 Rising number of neonatal care facilities worldwide to drive market
    • TABLE 72 NEONATAL MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.9 NEUROMONITORING DEVICES
    • TABLE 73 NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 74 NEUROMONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 75 NEUROMONITORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 6.9.1 EEG MACHINES
      • 6.9.1.1 Growing applications and technological advancements to favor market growth
    • TABLE 76 EEG MACHINES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.9.2 EMG MACHINES
      • 6.9.2.1 Availability of reimbursements for EMG-assisted surgeries to boost product demand
    • TABLE 77 EMG MACHINES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.9.3 CEREBRAL OXIMETERS
      • 6.9.3.1 Growing cases of hypoxia during surgical procedures to drive market growth
    • TABLE 78 CEREBRAL OXIMETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.9.4 ICP MONITORS
      • 6.9.4.1 Growing incidence of post-surgical cerebrovascular complications and TBIs to support adoption of ICP monitors
    • TABLE 79 ICP MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.9.5 MEG MACHINES
      • 6.9.5.1 High implementation and maintenance costs of MEG devices to hinder market growth
    • TABLE 80 MEG MACHINES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.9.6 TCD MACHINES
      • 6.9.6.1 Rising prevalence of strokes and cerebrovascular disorders to contribute to market growth
    • TABLE 81 TCD MACHINES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.10 WEIGHT MONITORING DEVICES
    • TABLE 82 WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 83 WEIGHT MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 84 WEIGHT MONITORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 6.10.1 DIGITAL WEIGHT MONITORING DEVICES
      • 6.10.1.1 Consumer preference for digital scales-a key market driver
    • TABLE 85 DIGITAL WEIGHT MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.10.2 ANALOG WEIGHT MONITORING DEVICES
      • 6.10.2.1 Rising prevalence of obesity and low cost of analog scales to support market growth
    • TABLE 86 ANALOG WEIGHT MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.11 OTHER PATIENT MONITORING DEVICES
    • TABLE 87 POLYSOMNOGRAPHY DEVICES OFFERED BY VARIOUS PLAYERS
    • TABLE 88 WEARABLE SLEEP MONITORING DEVICES OFFERED BY MARKET PLAYERS
    • TABLE 89 OTHER PATIENT MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 90 OTHER PATIENT MONITORING DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)

7 PATIENT MONITORING MARKET, BY END USER

  • 7.1 INTRODUCTION
    • TABLE 91 PATIENT MONITORING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 7.2 HOSPITALS & CLINICS
    • 7.2.1 ABILITY TO AFFORD HIGH INSTALLATION & MAINTENANCE COSTS OF PATIENT MONITORING TECHNOLOGIES TO BOOST MARKET
    • TABLE 92 PATIENT MONITORING MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 93 PATIENT MONITORING MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022-2029 (USD MILLION)
  • 7.3 AMBULATORY SURGICAL CENTERS
    • 7.3.1 COST-EFFECTIVENESS AND CONVENIENCE OF AMBULATORY SURGICAL CENTERS TO DRIVE DEMAND FOR AMBULATORY CARE
    • TABLE 94 PATIENT MONITORING MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • 7.4 HOME CARE SETTINGS
    • 7.4.1 REDUCED COST AND CONTINUOUS MONITORING OF VITAL INFORMATION IN HOME SETTINGS TO BOOST GROWTH
    • TABLE 95 PATIENT MONITORING MARKET FOR HOME CARE SETTINGS, BY REGION, 2022-2029 (USD MILLION)
  • 7.5 OTHER END USERS
    • TABLE 96 PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)

8 PATIENT MONITORING MARKET, BY REGION

  • 8.1 INTRODUCTION
    • TABLE 97 PATIENT MONITORING MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 8.2 NORTH AMERICA
    • FIGURE 28 NORTH AMERICA: PATIENT MONITORING MARKET SNAPSHOT
    • TABLE 98 NORTH AMERICA: PATIENT MONITORING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 99 NORTH AMERICA: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 100 NORTH AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 101 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 102 NORTH AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 103 NORTH AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 104 NORTH AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 105 NORTH AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 106 NORTH AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 107 NORTH AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 108 NORTH AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 109 NORTH AMERICA: PATIENT MONITORING MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 8.2.1 NORTH AMERICA: RECESSON IMPACT
    • 8.2.2 US
      • 8.2.2.1 Growing number of FDA approvals for patient monitoring devices to support market growth
    • TABLE 110 VC FUNDING IN PATIENT MONITORING MARKET IN US
    • TABLE 111 US: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 112 US: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 113 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 114 US: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 115 US: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 116 US: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 117 US: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 118 US: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 119 US: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 120 US: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 8.2.3 CANADA
      • 8.2.3.1 Growing public-private funding for research to drive market growth
    • TABLE 121 RESEARCH GRANTS IN PATIENT MONITORING MARKET IN CANADA
    • TABLE 122 RECENT DEVELOPMENTS IN CANADIAN PATIENT MONITORING MARKET
    • TABLE 123 CANADA: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 124 CANADA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 125 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 126 CANADA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 127 CANADA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 128 CANADA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 129 CANADA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 130 CANADA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 131 CANADA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 132 CANADA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 8.3 EUROPE
    • TABLE 133 PRODUCT APPROVALS IN EUROPEAN PATIENT MONITORING MARKET
    • TABLE 134 EUROPE: PATIENT MONITORING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 135 EUROPE: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 136 EUROPE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 137 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 138 EUROPE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 139 EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 140 EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 141 EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 142 EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 143 EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 144 EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 145 EUROPE: PATIENT MONITORING MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 8.3.1 EUROPE: RECESSION IMPACT
    • 8.3.2 GERMANY
      • 8.3.2.1 Rising healthcare expenditure and manufacturer expansion to boost market growth
    • TABLE 146 GERMANY: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 147 GERMANY: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 148 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 149 GERMANY: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 150 GERMANY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 151 GERMANY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 152 GERMANY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 153 GERMANY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 154 GERMANY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 155 GERMANY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 8.3.3 UK
      • 8.3.3.1 Increasing public & private investments to contribute to market growth
    • TABLE 156 UK: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 157 UK: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 158 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 159 UK: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 160 UK: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 161 UK: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 162 UK: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 163 UK: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 164 UK: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 165 UK: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 8.3.4 FRANCE
      • 8.3.4.1 Statutory health insurance system to support market growth
    • TABLE 166 FRANCE: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 167 FRANCE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 168 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 169 FRANCE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 170 FRANCE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 171 FRANCE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 172 FRANCE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 173 FRANCE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 174 FRANCE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 175 FRANCE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 8.3.5 ITALY
      • 8.3.5.1 Rising incidence of lifestyle diseases to drive adoption of patient monitoring devices
    • TABLE 176 ITALY: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 177 ITALY: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 178 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 179 ITALY: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 180 ITALY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 181 ITALY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 182 ITALY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 183 ITALY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 184 ITALY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 185 ITALY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 8.3.6 SPAIN
      • 8.3.6.1 Growing number of surgical procedures to drive market growth in Spain
    • TABLE 186 SPAIN: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 187 SPAIN: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 188 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 189 SPAIN: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 190 SPAIN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 191 SPAIN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 192 SPAIN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 193 SPAIN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 194 SPAIN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 195 SPAIN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 8.3.7 REST OF EUROPE
    • TABLE 196 KEY MERGERS & ACQUISITIONS AND PARTNERSHIPS IN PATIENT MONITORING MARKET IN ROE
    • TABLE 197 REST OF EUROPE: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 198 REST OF EUROPE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 199 REST OF EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 200 REST OF EUROPE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 201 REST OF EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 202 REST OF EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 203 REST OF EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 204 REST OF EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 205 REST OF EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 206 REST OF EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 8.4 ASIA PACIFIC
    • FIGURE 29 ASIA PACIFIC: PATIENT MONITORING MARKET SNAPSHOT
    • TABLE 207 ASIA PACIFIC: PATIENT MONITORING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 208 ASIA PACIFIC: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 209 ASIA PACIFIC: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 210 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 211 ASIA PACIFIC: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 212 ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 213 ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 214 ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 215 ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 216 ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 217 ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 218 ASIA PACIFIC: PATIENT MONITORING MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 8.4.1 ASIA PACIFIC: RECESSION IMAPCT
    • 8.4.2 JAPAN
      • 8.4.2.1 Large geriatric population and favorable reimbursement scenario to support market growth
    • TABLE 219 RECENT DEVELOPMENTS IN PATIENT MONITORING MARKET IN JAPAN
    • TABLE 220 JAPAN: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 221 JAPAN: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 222 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 223 JAPAN: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 224 JAPAN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 225 JAPAN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 226 JAPAN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 227 JAPAN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 228 JAPAN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 229 JAPAN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 8.4.3 CHINA
      • 8.4.3.1 Growing focus of local and international market players to favor market growth
    • TABLE 230 RECENT DEVELOPMENTS IN PATIENT MONITORING MARKET IN CHINA
    • TABLE 231 CHINA: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 232 CHINA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 233 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 234 CHINA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 235 CHINA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 236 CHINA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 237 CHINA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 238 CHINA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 239 CHINA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 240 CHINA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 8.4.4 INDIA
      • 8.4.4.1 Increasing government-implemented healthcare initiatives to support market growth
    • TABLE 241 INDIA: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 242 INDIA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 243 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 244 INDIA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 245 INDIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 246 INDIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 247 INDIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 248 INDIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 249 INDIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 250 INDIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 8.4.5 AUSTRALIA
      • 8.4.5.1 R&D Tax Incentive Program to support market growth
    • TABLE 251 AUSTRALIA: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 252 AUSTRALIA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 253 AUSTRALIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 254 AUSTRALIA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 255 AUSTRALIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 256 AUSTRALIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 257 AUSTRALIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 258 AUSTRALIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 259 AUSTRALIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 260 AUSTRALIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 8.4.6 SOUTH KOREA
      • 8.4.6.1 Supportive government initiatives to drive market growth
    • TABLE 261 SOUTH KOREA: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 262 SOUTH KOREA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 263 SOUTH KOREA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 264 SOUTH KOREA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 265 SOUTH KOREA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 266 SOUTH KOREA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 267 SOUTH KOREA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 268 SOUTH KOREA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 269 SOUTH KOREA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 270 SOUTH KOREA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 8.4.7 REST OF ASIA PACIFIC
    • TABLE 271 RECENT DEVELOPMENTS IN PATIENT MONITORING MARKET IN ROAPAC
    • TABLE 272 REST OF ASIA PACIFIC: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 273 REST OF ASIA PACIFIC: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 274 REST OF ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 275 REST OF ASIA PACIFIC: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 276 REST OF ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 277 REST OF ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 278 REST OF ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 279 REST OF ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 280 REST OF ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 281 REST OF ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 8.5 LATIN AMERICA
    • TABLE 282 LATIN AMERICA: PATIENT MONITORING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 283 LATIN AMERICA: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 284 LATIN AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 285 LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 286 LATIN AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 287 LATIN AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 288 LATIN AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 289 LATIN AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 290 LATIN AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 291 LATIN AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 292 LATIN AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 293 LATIN AMERICA: PATIENT MONITORING MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 8.5.1 LATIN AMERICA: RECESSION IMAPCT
    • 8.5.2 BRAZIL
      • 8.5.2.1 Brazil to dominate LATAM market
    • TABLE 294 BRAZIL: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 295 BRAZIL: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 296 BRAZIL: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 297 BRAZIL: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 298 BRAZIL: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 299 BRAZIL: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 300 BRAZIL: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 301 BRAZIL: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 302 BRAZIL: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 303 BRAZIL: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 8.5.3 MEXICO
      • 8.5.3.1 Favorable investment scenario for medical device manufacturers to drive market growth
    • TABLE 304 MEXICO: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 305 MEXICO: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 306 MEXICO: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 307 MEXICO: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 308 MEXICO: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 309 MEXICO: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 310 MEXICO: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 311 MEXICO: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 312 MEXICO: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 313 MEXICO: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 8.5.4 REST OF LATIN AMERICA
    • TABLE 314 REST OF LATIN AMERICA: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 315 REST OF LATIN AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 316 REST OF LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 317 REST OF LATIN AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 318 REST OF LATIN AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 319 REST OF LATIN AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 320 REST OF LATIN AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 321 REST OF LATIN AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 322 REST OF LATIN AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 323 REST OF LATIN AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 8.6 MIDDLE EAST & AFRICA
    • 8.6.1 AWARENESS INITIATIVES TO DRIVE ADOPTION OF PATIENT MONITORING DEVICES IN REGION
    • TABLE 324 MIDDLE EAST & AFRICA: PATIENT MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 325 MIDDLE EAST & AFRICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 326 MIDDLE EAST & AFRICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 327 MIDDLE EAST & AFRICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 328 MIDDLE EAST & AFRICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 329 MIDDLE EAST & AFRICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 330 MIDDLE EAST & AFRICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 331 MIDDLE EAST & AFRICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 332 MIDDLE EAST & AFRICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 333 MIDDLE EAST & AFRICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 334 MIDDLE EAST & AFRICA: PATIENT MONITORING MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 8.6.2 MIDDLE EAST & AFRICA: RECESSION IMAPCT

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 9.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PATIENT MONITORING PLAYERS
  • 9.3 REVENUE ANALYSIS
    • FIGURE 30 REVENUE ANALYSIS OF TOP PLAYERS IN PATIENT MONITORING MARKET, 2019-2023 (USD MILLION)
  • 9.4 MARKET SHARE ANALYSIS
    • 9.4.1 GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
    • FIGURE 31 BLOOD GLUCOSE MONITORING DEVICES MARKET SHARE ANALYSIS, 2023
    • 9.4.2 GLOBAL CARDIAC MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
    • FIGURE 32 CARDIAC MONITORING DEVICES MARKET SHARE ANALYSIS, 2023
    • 9.4.3 GLOBAL MULTIPARAMETER MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
    • FIGURE 33 MULTIPARAMETER MONITORING DEVICES MARKET SHARE ANALYSIS, 2023
    • 9.4.4 GLOBAL HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
    • FIGURE 34 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET SHARE ANALYSIS, 2023
    • 9.4.5 GLOBAL FETAL & NEONATAL MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
    • FIGURE 35 FETAL & NEONATAL MONITORING DEVICES MARKET SHARE ANALYSIS, 2023
    • TABLE 335 PATIENT MONITORING MARKET: DEGREE OF COMPETITION
  • 9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
    • 9.5.1 STARS
    • 9.5.2 EMERGING LEADERS
    • 9.5.3 PERVASIVE PLAYERS
    • 9.5.4 PARTICIPANTS
    • FIGURE 36 PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
    • 9.5.5 COMPANY FOOTPRINT: KEY PLAYERS
    • FIGURE 37 COMPANY FOOTPRINT (15 COMPANIES)
    • TABLE 336 PRODUCT FOOTPRINT (15 COMPANIES)
    • TABLE 337 REGIONAL FOOTPRINT (15 COMPANIES)
  • 9.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES
    • 9.6.1 PROGRESSIVE COMPANIES
    • 9.6.2 RESPONSIVE COMPANIES
    • 9.6.3 DYNAMIC COMPANIES
    • 9.6.4 STARTING BLOCKS
    • FIGURE 38 PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
    • 9.6.5 COMPETITIVE BENCHMARKING
    • TABLE 338 PATIENT MONITORING MARKET: DETAILED LIST OF KEY EMERGING PLAYERS/STARTUPS
    • TABLE 339 PATIENT MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • 9.7 COMPETITIVE SCENARIO
    • 9.7.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 340 PATIENT MONITORING MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-OCTOBER 2023
    • 9.7.2 DEALS
    • TABLE 341 PATIENT MONITORING MARKET: DEALS, JANUARY 2021-FEBRUARY 2024
  • 9.8 COMPANY VALUATION & FINANCIAL METRICS
    • FIGURE 39 EV/EBITDA OF KEY VENDORS
    • FIGURE 40 5-YEAR STOCK BETA OF KEY VENDORS
  • 9.9 PRODUCT/BRAND COMPARISON
    • FIGURE 41 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL (2023)

10 COMPANY PROFILES

  • 10.1 KEY PLAYERS
  • (Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)**
    • 10.1.1 MEDTRONIC PLC
    • TABLE 342 MEDTRONIC PLC: COMPANY OVERVIEW
    • FIGURE 42 MEDTRONIC PLC: COMPANY SNAPSHOT (2023)
    • TABLE 343 MEDTRONIC PLC: PRODUCTS OFFERED
    • TABLE 344 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS
    • TABLE 345 MEDTRONIC PLC: DEALS
    • 10.1.2 ABBOTT LABORATORIES
    • TABLE 346 ABBOTT LABORATORIES: COMPANY OVERVIEW
    • FIGURE 43 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
    • TABLE 347 ABBOTT LABORATORIES: PRODUCTS OFFERED
    • TABLE 348 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS
    • TABLE 349 ABBOTT LABORATORIES: DEALS
    • 10.1.3 DEXCOM, INC.
    • TABLE 350 DEXCOM, INC.: COMPANY OVERVIEW
    • FIGURE 44 DEXCOM, INC.: COMPANY SNAPSHOT (2023)
    • TABLE 351 DEXCOM, INC.: PRODUCTS OFFERED
    • TABLE 352 DEXCOM, INC.: PRODUCT LAUNCHES & APPROVALS
    • 10.1.4 GE HEALTHCARE
    • TABLE 353 GE HEALTHCARE: COMPANY OVERVIEW
    • FIGURE 45 GE HEALTHCARE: COMPANY SNAPSHOT (2023)
    • TABLE 354 GE HEALTHCARE: PRODUCTS OFFERED
    • TABLE 355 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS
    • TABLE 356 GE HEALTHCARE: DEALS
    • 10.1.5 PHILIPS HEALTHCARE
    • TABLE 357 PHILIPS HEALTHCARE: COMPANY OVERVIEW
    • FIGURE 46 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2023)
    • TABLE 358 PHILIPS HEALTHCARE: PRODUCTS OFFERED
    • TABLE 359 PHILIPS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS
    • TABLE 360 PHILIPS HEALTHCARE: DEALS
    • 10.1.6 NIHON KOHDEN CORPORATION
    • TABLE 361 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
    • FIGURE 47 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023)
    • TABLE 362 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED
    • TABLE 363 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS
    • 10.1.7 MINDRAY MEDICAL INTERNATIONAL LTD.
    • TABLE 364 MINDRAY MEDICAL INTERNATIONAL LTD.: COMPANY OVERVIEW
    • FIGURE 48 MINDRAY MEDICAL INTERNATIONAL LTD.: COMPANY SNAPSHOT (2022)
    • TABLE 365 MINDRAY MEDICAL INTERNATIONAL LTD.: PRODUCTS OFFERED
    • TABLE 366 MINDRAY MEDICAL INTERNATIONAL LTD.: PRODUCT LAUNCHES & APPROVALS
    • TABLE 367 MINDRAY MEDICAL INTERNATIONAL LTD.: DEALS
    • 10.1.8 EDWARDS LIFESCIENCES CORPORATION
    • TABLE 368 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
    • FIGURE 49 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023)
    • TABLE 369 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED
    • 10.1.9 GETINGE AB
    • TABLE 370 GETINGE AB: COMPANY OVERVIEW
    • FIGURE 50 GETINGE AB.: COMPANY SNAPSHOT (2023)
    • TABLE 371 GETINGE AB: PRODUCTS OFFERED
    • TABLE 372 GETINGE AB: PRODUCT LAUNCHES & APPROVALS
    • TABLE 373 GETINGE AB: DEALS
    • 10.1.10 BAXTER INTERNATIONAL (HILL-ROM HOLDINGS, INC.)
    • TABLE 374 BAXTER INTERNATIONAL: COMPANY OVERVIEW
    • FIGURE 51 BAXTER INTERNATIONAL: COMPANY SNAPSHOT (2023)
    • TABLE 375 BAXTER INTERNATIONAL: PRODUCTS OFFERED
    • TABLE 376 BAXTER INTERNATIONAL: PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS
    • TABLE 377 BAXTER INTERNATIONAL: DEALS
    • 10.1.11 DRAGERWERK AG & CO. KGAA
    • TABLE 378 DRAGERWERK AG & CO. KGAA: COMPANY OVERVIEW
    • FIGURE 52 DRAGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023)
    • TABLE 379 DRAGERWERK AG & CO. KGAA: PRODUCTS OFFERED
    • 10.1.12 BOSTON SCIENTIFIC CORPORATION
    • TABLE 380 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
    • FIGURE 53 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 381 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
    • TABLE 382 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS
    • TABLE 383 BOSTON SCIENTIFIC CORPORATION: DEALS
    • 10.1.13 MASIMO CORPORATION
    • TABLE 384 MASIMO CORPORATION: COMPANY OVERVIEW
    • FIGURE 54 MASIMO CORPORATION: COMPANY SNAPSHOT (2023)
    • TABLE 385 MASIMO CORPORATION: PRODUCTS OFFERED
    • TABLE 386 MASIMO CORPORATION: PRODUCT LAUNCHES & APPROVALS
    • TABLE 387 MASIMO CORPORATION: DEALS
    • 10.1.14 OMRON CORPORATION
    • TABLE 388 OMRON CORPORATION: COMPANY OVERVIEW
    • FIGURE 55 OMRON CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 389 OMRON CORPORATION: PRODUCTS OFFERED
    • TABLE 390 OMRON CORPORATION: PRODUCT LAUNCHES & APPROVALS
    • TABLE 391 OMRON CORPORATION: DEALS
    • 10.1.15 ARCHIMED SAS (NATUS MEDICAL)
    • TABLE 392 ARCHIMED SAS (NATUS MEDICAL): BUSINESS OVERVIEW
    • TABLE 393 ARCHIMED SAS (NATUS MEDICAL): PRODUCTS OFFERED
    • TABLE 394 ARCHIMED SAS (NATUS MEDICAL): DEALS
    • 10.1.16 COMPUMEDICS LIMITED
    • TABLE 395 COMPUMEDICS LIMITED: BUSINESS OVERVIEW
    • FIGURE 56 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2023)
    • TABLE 396 COMPUMEDICS LIMITED: PRODUCTS OFFERED
    • TABLE 397 COMPUMEDICS LIMITED: PRODUCT LAUNCHES & APPROVALS
    • TABLE 398 COMPUMEDICS LIMITED: DEALS
    • 10.1.17 NONIN MEDICAL, INC.
    • TABLE 399 NONIN MEDICAL, INC.: BUSINESS OVERVIEW
    • TABLE 400 NONIN MEDICAL, INC.: PRODUCTS OFFERED
    • TABLE 401 NONIN MEDICAL, INC.: PRODUCT LAUNCHES & APPROVALS
  • 10.2 OTHER PLAYERS
    • 10.2.1 BIOTRONIK
    • 10.2.2 SCHILLER AG
    • 10.2.3 SENSEONICS
    • 10.2.4 CARDIOMO
    • 10.2.5 VITLS
    • 10.2.6 NETEERA
    • 10.2.7 QARDIO
    • 10.2.8 VIVIFY HEALTH
    • 10.2.9 IRHYTHM TECHNOLOGIES, INC.
    • 10.2.10 OSYPKA MEDICAL
    • 10.2.11 CARDINAL HEALTH
    • 10.2.12 MERIT MEDICAL SYSTEMS
  • *Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

11 APPENDIX

  • 11.1 DISCUSSION GUIDE
  • 11.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.3 CUSTOMIZATION OPTIONS
  • 11.4 RELATED REPORTS
  • 11.5 AUTHOR DETAILS